EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, KYMR: Kymera Therapeutics Inc

10 Mar 26 15:59
LAST:

84.63

CHANGE:
 0.46		OPEN:
84.54		HIGH:
86.92		ASK:
0.00		VOLUME:
183.2K
CHG(%):
0.54		PREV:
85.04		LOW:
83.88		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
10 Mar 2684.8686.9283.8884.58601.5K
09 Mar 2682.8585.7181.4485.04438.1K
06 Mar 2681.5584.1280.1883.49557.2K
05 Mar 2685.5386.9281.5083.521.04M
04 Mar 2686.9787.6683.3686.111.04M
03 Mar 2687.4189.2085.9886.35780.7K
02 Mar 2689.2491.0087.1990.101.02M
27 Feb 2692.1493.9988.8091.351.24M
26 Feb 2686.0095.9083.7495.031.4M
25 Feb 2691.4093.6489.0690.681.06M

PROFILE

Name:Kymera Therapeutics Inc
About:Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis. The company also develops STAT6, a type 2 inflammation in allergic and atopic diseases; and TYK2 to treat autoimmune and inflammatory diseases. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside of the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:500 North Beacon Street, Watertown, MA, United States, 02472
Website:https://www.kymeratx.com
CUSIP:501575104
CIK:0001815442
ISIN:US5015751044
FIGI:BBG00SDHC8D1

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-20.04 
Forward P/E:-20.81 
PEG Ratio:-0.31 
Price to Sales:98.89 
Price to Book:5.81 
Operating Margin:-7.37 
Return on Assets:-0.20 
Return on Equity:-0.33 
EPS Ratio:-3.76 
Revenue:44.71M 
Shares:80.0M 
Market Cap:6.77B 

TECHNICAL INDICATORS

MA5:84.550.1%
MA10:87.633.5%
MA20:86.382.1%
MA50:79.226.8%
MA100:73.9414.5%
MA200:59.8441.4%
STO9:8.78 
STO14:8.78 
RSI14:48.90
WPR14:-90.55 
MTM14:-1.92
ROC14:-0.02 
ATR:4.88 
Week High:89.205.4%
Week Low:80.185.6%
Month High:95.9013.3%
Month Low:76.5141.4%
Year High:103.0021.7%
Year Low:19.44335.3%